Navigation Links
Nektar Therapeutics' President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston
Date:3/1/2011

SAN FRANCISCO, March 1, 2011 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the 31st Annual Cowen and Company Healthcare Conference at the Boston Marriott Copley Place on Tuesday, March 8, 2011 at 11:00 a.m. Eastern time.

The presentation will be accessible via a Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website http://www.nektar.com. This webcast will be available for replay until April 8, 2011.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for Nektar's oral NKTR-118 late-stage development program to treat opioid-induced constipation and its NKTR-119 earlier stage development program for the treatment of pain without constipation side effects.  NKTR-181 is a novel mu-opioid analgesic molecule that is being prepared for Phase 1 clinical studies. In oncology, NKTR-102, a novel topoisomerase I-inhibitor, is being evaluated in Phase 2 clinical studies for the treatment of ovarian, breast and colorectal cancers. NKTR-105, a novel anti-mitotic agent, is in a Phase 1 clinical study in cancer patients with refractory solid tumors.

Nektar's technology has enabled seven approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia(R) for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS(R) for hepatitis C and Amgen's Neulasta(R) for neutropenia.

Nektar is headquartered in S
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2010 on Tuesday, March 1, 2011, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Third Quarter 2010 Financial Results
4. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
5. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
6. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
7. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
8. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
9. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
10. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
11. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Boston Scientific Corporation (NYSE: ... the annual EuroPCR Scientific Program May 21-24 in ... to present a particularly rich and diversified set of ... Dawkins , M.D., global chief medical officer, Boston ... be presented, including the NG PROMUS trial, which evaluated ...
(Date:5/16/2013)...  PTC Therapeutics, Inc., today announced that it has ... U.S. Securities and Exchange Commission ("SEC") relating to the ... number of shares to be offered and the price ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) J.P. ... managers for the offering. Cowen and Company is acting ...
(Date:5/16/2013)... SYDNEY , May 16, 2013  HeartWare International, ... leading innovator of less invasive, miniaturized circulatory support technologies that ... that CEO Doug Godshall is scheduled ... 11:00 a.m. EDT on Monday, May 20, 2013.  The conference ... York Hotel. A live webcast of the Company,s ...
Breaking Medicine Technology:Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
... announces that a new market research report is available ... http://www.reportlinker.com/p0357031/Regenerative-Medicine-Markets.html Regenerative ... human tissue by using laboratory-grown or therapeutically-induced human tissue ... the ability to repair or replace damaged human tissue ...
... YORK, Dec. 29, 2010 Reportlinker.com announces that ... its catalogue: 2010-2015 In-depth Research ... http://www.reportlinker.com/p0356862/2010-2015-In-depth-Research-Report-on-China-Sodium-Fluoride-Industry.html Report ... State Statistical Bureau, General Administration of Custom, Ministry ...
Cached Medicine Technology:Reportlinker Adds Regenerative Medicine Markets 2Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry 2
(Date:5/18/2013)... who swallow high-powered magnets often need surgery and other ... new study. The researchers, from the Louisiana State ... than 79 percent of children who swallowed very strong ... in which a tube containing a camera is inserted ... cases can be treated through observation or by pumping ...
(Date:5/18/2013)... is associated with a reduced risk of primary ... Clinic research shows. The findings were being presented ... Orlando, Fla. , PSC is an inflammatory ... inflammation and subsequent fibrosis that can lead to ... cancer. , "While rare, PSC has extremely detrimental ...
(Date:5/18/2013)... New York, New York (PRWEB) May 18, 2013 ... Inc.’s Gynecare pelvic mesh products continue to move forward ... County Superior Court, Bernstein Liebhard LLP reports. According to ... Management Conference in the Ethicon pelvic mesh litigation will ... indicate that 2,755 complaints have been filed in the ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 TheBeautyPlace.com answers ... Pattern hair loss is not a result of stress, ... to Men’s Fitness Magazine, 70% of men suffer from ... Strength is renowned for hair transplant surgery, but ... male pattern baldness known as Bosley Professional Strength. Their ...
(Date:5/18/2013)... Philadelphia, PA (PRWEB) May 18, 2013 ... as indulging in healthy snacks and drinking more water ... weight loss and, ultimately, a healthier lifestyle overall. ... to achieve the best weight loss can be difficult ... treatments into their diet plans to help patients get ...
Breaking Medicine News(10 mins):Health News:Swallowing Magnets Can Be Fatal for Children 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 3
... found measurable gains in those with moderate to severe ... implanting specialized cells found in the human eye into ... were able to reduce symptoms and improve quality of ... The new treatment, dubbed Spheramine, reduced symptoms experienced when ...
... thing for a typical adolescent and quite another to ... an adult world. A unique program, the Indiana University ... Conditions of Childhood (CYACC) is helping these youths spread ... pediatricians at Riley Hospital for Children have been at ...
... leads PRO collection in community ... ... Oncology Services,(SOS), Inc. a research-based health-outcomes company specializing in,oncology, issued the ... cancer community., "Appropriate use of PRO information in the community ...
... Unites Hospitals to Reduce Critical Care Physician Shortage, Improve Care ... ... WASHINGTON, April 28 Today, six hospitals serving,patients in rural ... the VISICU eICU(R) Program in each of their,intensive care units. Made ...
... been chosen as the recipient of the 2008 Alzheimer ... recognition of his outstanding work, "Phagocytosis of amyloid-beta and ... by M. Fiala, D.H. Cribbs, M. Rosenthal and G. ... Associate Editors of the journal select an outstanding article ...
... N.J., April 28 Milestone,Scientific Inc. (OTC Bulletin Board: MLSS), the recognized ... its award winning STA(TM) System at the upcoming,California Dental Association (CDA) 2008 ... May 4, 2008, WHERE: Booth #1641 ... 800 West Katella Avenue ...
Cached Medicine News:Health News:Eye Cell Implants Improve Parkinson's Symptoms 2Health News:Eye Cell Implants Improve Parkinson's Symptoms 3Health News:Transitioning patients with pediatric disease to adulthood 2Health News:Systematic Review of Patient-Reported Outcomes (PROs) Can Reduce Cost of Cancer Care 2Health News:Rural Maryland Hospitals Form Unprecedented Collaborative to Improve Patient Care 2Health News:Rural Maryland Hospitals Form Unprecedented Collaborative to Improve Patient Care 3Health News:Milan Fiala, MD, receives 2008 Alzheimer Award 2Health News:Milestone Scientific to Exhibit at the California Dental Association (CDA) Spring Scientific Session 2Health News:Milestone Scientific to Exhibit at the California Dental Association (CDA) Spring Scientific Session 3Health News:Milestone Scientific to Exhibit at the California Dental Association (CDA) Spring Scientific Session 4
... to connect an infusion ... pump, and then to ... order to conduct urodynamics ... Laborie Medical Technologies infusion ...
Used for cystometry and urethral pressure profilometry. A loop is employed to enhance catheter retention and stabilization within the bladder. Supplied sterile in peel-open packages. Intended for one...
... Used for cystometry and urethral pressure ... for faster filling of the bladder ... Dual lumen catheter construction allows the ... is performed. Triple lumen catheter construction ...
... The Triage® Cardiac Panel is ... the rapid quantitative determination of ... in ethylenediaminetetraacetic acid (EDTA) whole ... test is used as an ...
Medicine Products: